EmployblEmploybl logo
employbl
Freenome logo

Freenome Funding & Investors

Freenome, Inc. provides clinical research services. The Company develops and creates screening, diagnosis, and treatment of age-associated clinical conditions. Freenome serves patients and the healthcare sector in the United States.

freenome.com

Total Amount Raised: $1,351,550,080

Freenome Funding Rounds

  • Series E

    $254,000,000

    Series E Investors

    Roche
    Intermountain Ventures
    Eventide Asset Management
    Squarepoint Capital
    Polaris Partners
    Bain Capital Life Sciences
    Ra Capital Management
    Cormorant Capital
    DCVC Bio
    Perceptive Advisors
    Quest Diagnostics
    Pura Vida Investments
    Andreessen Horowitz
    Artis Ventures
    Sands Capital Ventures
    Section 32
    ArrowMark Partners
    T. Rowe Price
    BrightEdge Fund
    ARK Investment Management

  • Corporate Round

    $290,000,000

    Corporate Round Investors

    Roche

  • Series D

    $300,000,000

    Series D Investors

    Perceptive Advisors
    Ra Capital Management
    Andreessen Horowitz
    BrightEdge Fund
    Catalio Capital Management
    Bain Capital Life Sciences
    Artis Ventures
    Cormorant Capital
    DCVC
    Fidelity Investments
    Farallon Capital Management
    Janus Henderson
    Kaiser Permanente
    Novartis
    Ridgeback Capital
    Polaris Partners
    Roche Venture Fund
    Rock Springs Capital
    Section 32
    Sands Capital Ventures
    T. Rowe Price
    Soleus Capital
    ArrowMark Partners
    HBM Healthcare Investments
    Byers Capital
    Eventide Asset Management
    Intermountain Ventures
    Suvretta Capital Management
    Logos Capital
    Pura Vida Investments
    GV

  • Series C

    $270,000,000

    Series C Investors

    Bain Capital Life Sciences
    Perceptive Advisors
    Ra Capital Management
    Farallon Capital Management
    Fidelity Investments
    Janus Henderson
    BrightEdge Fund
    Catalio Capital Management
    Cormorant Asset Management
    EcoR1 Capital
    Rock Springs Capital
    Andreessen Horowitz
    Sands Capital Ventures
    DCVC
    Novartis
    GV
    Soleus Capital
    Roche Venture Fund
    Kaiser Permanente Ventures
    Section 32
    Polaris Partners
    T. Rowe Price

  • Series B

    $160,000,000

    Series B Investors

    Polaris Partners
    Ra Capital Management
    T. Rowe Price
    Perceptive Advisors
    Verily Life Sciences
    Section 32
    BrightEdge Fund
    Andreessen Horowitz
    DCVC
    Kaiser Permanente Ventures
    Roche Venture Fund
    GV
    Longevity Vision Fund
    Soleus Capital
    Artis Ventures
    dRx Capital

  • Series A

    $7,000,000

    Series A Investors

    Section 32
    Anne Wojcicki
    Andreessen Horowitz
    Asset Management Ventures
    DCVC
    Founders Fund
    Innovation Endeavors
    Polaris Partners
    S28 Capital
    Verily Life Sciences
    GV
    CRV

  • Series A

    $65,000,000

    Series A Investors

    Andreessen Horowitz
    GV
    Polaris Partners
    Innovation Endeavors
    S28 Capital
    Asset Management Ventures
    CRA International
    AME Cloud Ventures
    Allen & Company
    DCVC
    Founders Fund
    Agent Capital

  • Seed

    $5,550,000

    Seed Investors

    Andreessen Horowitz
    Founders Fund
    DCVC
    Third Kind Venture Capital
Funding info provided by Diffbot.